Abstract
Roflumilast reduces exacerbations in patients with severe chronic obstructive pulmonary disease associated with chronic bronchitis and a history of exacerbations. Further characterization of patients most likely to benefit is warranted. Define characteristics that most robustly identify patients who derive greatest exacerbation risk reduction with roflumilast. Predefined, pooled analyses of REACT (Roflumilast in the Prevention of COPD Exacerbations While Taking Appropriate Combination Treatment; NCT01329029) and RE2SPOND (Roflumilast Effect on Exacerbations in Patients on Dual [LABA/ICS] Therapy; NCT01443845) multicenter, randomized, double-blind, placebo-controlled studies. The primary endpoint was rate of moderate or severe exacerbations per patient per year. In the overall intention-to-treat population (n = 4,287), roflumilast reduced moderate or severe exacerbations by 12.3% (rate ratio, 0.88, 95% confidence interval, 0.80-0.97; P = 0.0086) and severe exacerbations by 16.1% (0.84; 0.71-0.99; P = 0.0409) versus placebo. The reduction in moderate or severe exacerbations with roflumilast was most pronounced in patients who had been hospitalized for an exacerbation in the prior year (0.74; 0.63-0.88; P = 0.0005); had more than ...Continue Reading
References
Aug 2, 2005·Thorax·J J Soler-CataluñaR Ochando
Jun 19, 2007·Thorax·Diana C GrootendorstKlaus F Rabe
Sep 1, 2009·Lancet·Peter M A CalverleyUNKNOWN M2-124 and M2-125 study groups
Sep 1, 2009·Lancet·Leonardo M FabbriUNKNOWN M2-127 and M2-128 study groups
Sep 17, 2010·The New England Journal of Medicine·John R HurstUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Jan 29, 2011·Respiratory Research·Stephen I RennardFernando J Martinez
Jul 9, 2011·The European Respiratory Journal·E D BatemanL M Fabbri
Feb 17, 2015·Lancet·Fernando J MartinezKlaus F Rabe
Apr 17, 2015·The Lancet. Respiratory Medicine·Steven PascoeIan D Pavord
May 7, 2015·Lancet·Prescott G WoodruffFernando J Martinez
Jun 9, 2015·American Journal of Respiratory and Critical Care Medicine·Salman H SiddiquiDave Singh
Nov 21, 2015·Thorax·Ian D PavordNeil C Barnes
Apr 14, 2016·The Lancet. Respiratory Medicine·Henrik WatzPeter M A Calverley
Aug 31, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Stephen I RennardHaiyuan Zhu
Sep 2, 2016·American Journal of Respiratory and Critical Care Medicine·Jadwiga A Wedzicha
Sep 2, 2016·American Journal of Respiratory and Critical Care Medicine·Fernando J MartinezStephen I Rennard
Dec 17, 2016·COPD·Juan Luis García-RiveroMarc Miravitlles
Mar 18, 2017·American Journal of Respiratory and Critical Care Medicine·Peter M A CalverleyHenrik Watz
May 11, 2017·Clinical Science·Rahul ShrimankerIan D Pavord
Jun 12, 2017·The Lancet. Respiratory Medicine·Mona BafadhelRichard E K Russell
Jul 3, 2017·The Lancet. Respiratory Medicine·MeiLan K HanUNKNOWN SPIROMICS investigators
Jul 7, 2017·The European Respiratory Journal·Klaus F RabeLeonardo M Fabbri
Sep 11, 2017·The European Respiratory Journal·Jadwiga A WedzichaJerry A Krishnan
Oct 22, 2017·Chest·Olivier Le RouzicBruno Housset
Nov 24, 2017·The European Respiratory Journal·Klaus F RabeLeonardo M Fabbri
Citations
Nov 22, 2018·Expert Opinion on Pharmacotherapy·Ioana AlexaCristina Grigorescu
Feb 7, 2019·Expert Opinion on Pharmacotherapy·Dhuha Al-SajeeGail M Gauvreau
Mar 31, 2019·Expert Review of Respiratory Medicine·Craig P Hersh
Jul 26, 2019·Health Technology Assessment : HTA·Graham DevereuxDavid Price
May 1, 2019·Molecular Pharmacology·Radhika JoshiMark A Giembycz
Jun 29, 2018·American Journal of Respiratory and Critical Care Medicine·Bartolome R Celli
Mar 7, 2020·The Korean Journal of Internal Medicine·Chin Kook Rhee, Deog Kyeom Kim
May 16, 2020·Journal of Clinical Medicine·Imane Achir AlispahicJens-Ulrik Stæhr Jensen
Oct 16, 2019·ELife·Atiqur RahmanLynne R Prince
Dec 29, 2018·American Journal of Respiratory and Critical Care Medicine·Robert A StockleyDave Singh
Apr 9, 2019·American Journal of Respiratory and Critical Care Medicine·Wassim W LabakiSurya P Bhatt
Oct 17, 2018·JAMA : the Journal of the American Medical Association·Graham DevereuxDavid Price
Apr 29, 2020·The European Respiratory Journal·Dave SinghMirco Govoni
Sep 24, 2020·Respiratory Research·Dave SinghMarie Anna Nandeuil
Aug 11, 2019·Respiratory Research·Dave SinghMarie Anna Nandeuil
Nov 5, 2020·Fundamental & Clinical Pharmacology·Hélène SalvatorPhilippe Devillier
Dec 4, 2020·Journal of Pharmacy Practice·Dennis Williams
Dec 10, 2020·Journal of Cellular and Molecular Medicine·Dave SinghMirco Govoni
Dec 29, 2020·Frontiers in Pharmacology·Hélène SalvatorPhilippe Devillier
Feb 10, 2021·Expert Review of Clinical Pharmacology·Maria Gabriella MateraMario Cazzola
Apr 9, 2021·Respirology : Official Journal of the Asian Pacific Society of Respirology·Dave Singh
Apr 22, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Kay Por YipElizabeth Sapey
Sep 3, 2019·The Journal of Allergy and Clinical Immunology·Leonard B BacharierHirohito Kita
Jun 26, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Evgeni MekovMarc Miravitlles
Jul 3, 2021·Diagnostics·Peter M A Calverley, Paul Phillip Walker
Nov 4, 2021·Drugs·Dave SinghAlexander G Mathioudakis
Oct 10, 2021·Chest·Clarus Leung, Don D Sin